tiprankstipranks
Upstream Bio, Inc. (UPB)
NASDAQ:UPB
US Market

Compare Upstream Bio, Inc. (UPB) vs. Competitors

260 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Upstream Bio, Inc.
$30.30
$535.49M
-10.19
62.11%
6 Buy
1 Hold
0 Sell
Strong Buy
Theravance Biopharma
$16.60
$854.78M
8.89
99.52%
3 Buy
3 Hold
0 Sell
Moderate Buy
Bicycle Therapeutics
$4.98
$345.45M
-2.24
-21.94%
4 Buy
3 Hold
0 Sell
Moderate Buy
Prime Medicine, Inc.
$3.54
$639.15M
-2.57
207.83%
4 Buy
1 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$21.61
$1.41B
-6.67
130.63%
8 Buy
2 Hold
0 Sell
Strong Buy
Zenas BioPharma, Inc.
$20.86
$1.20B
-1.76
208.12%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
UPB
Upstream Bio, Inc.
9.84
3.31
50.69%
TBPH
Theravance Biopharma
16.60
8.07
94.61%
BCYC
Bicycle Therapeutics
4.98
-1.90
-27.62%
PRME
Prime Medicine, Inc.
3.54
2.29
183.20%
BCAX
Bicara Therapeutics Inc.
21.61
11.21
107.79%
ZBIO
Zenas BioPharma, Inc.
20.86
13.37
178.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts